Adriamycin effect on the Lewis lung carcinoma. Comparison between the original line and its derivative subline
- 1 September 1980
- journal article
- research article
- Published by Elsevier in European Journal of Cancer (1965)
- Vol. 16 (9), 1251-1255
- https://doi.org/10.1016/0014-2964(80)90185-1
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- In Vitro and in Vivo Selection of two Lewis Lung Carcinoma Cell LinesTumori Journal, 1979
- Cyclophosphamide and Iphosphamide against Lewis Lung Carcinoma: Evaluation of Toxic and Therapeutic EffectsTumori Journal, 1979
- Isolation From a Murine Fibrosarcoma of Cell Lines With Enhanced Plating Efficiency In Vitro 2 3JNCI Journal of the National Cancer Institute, 1978
- TUMOR HETEROGENEITY AND BIOLOGY OF CANCER INVASION AND METASTASIS1978
- DISTRIBUTION AND ANTI-TUMOR ACTIVITY OF ADRIAMYCIN GIVEN IN A HIGH-DOSE AND A REPEATED LOW-DOSE SCHEDULE TO MICE1978
- HETEROGENEITY IN DRUG SENSITIVITY AMONG TUMOR-CELL SUB-POPULATIONS OF A SINGLE MAMMARY-TUMOR1978
- Antineoplastic Activity and Pharmacokinetics of Adriamycin and Daunomycin in Tumor Bearing MiceOncology, 1977